Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-24 Sale | 2022-05-26 5:30 pm | ANTARES PHARMA INC. | ATRS | ROCHE ROBERT P JR Director | 167,817 | $5.6 | $939,775 | 0 (Direct) | View |
| 2022-05-24 Sale | 2022-05-26 5:28 pm | ANTARES PHARMA INC. | ATRS | GUETH ANTON Director | 467,577 | $5.6 | $2,618,431 | 0 (Indirect Direct) | View |
| 2022-05-24 Sale | 2022-05-26 5:27 pm | ANTARES PHARMA INC. | ATRS | Richardson Peter C See Remarks | 50,613 | $5.6 | $283,433 | 0 (Direct) | View |
| 2022-05-24 Sale | 2022-05-26 5:26 pm | ANTARES PHARMA INC. | ATRS | Smith Karen L. Director | 79,645 | $5.6 | $446,012 | 0 (Direct) | View |
| 2022-05-24 Sale | 2022-05-26 5:26 pm | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 170,575 | $5.6 | $955,220 | 0 (Direct) | View |
| 2022-05-24 Sale | 2022-05-26 5:25 pm | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J See Remarks | 740,843 | $5.6 | $4,148,721 | 0 (Direct) | View |
| 2022-05-24 Sale | 2022-05-26 5:24 pm | ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director | 249,858 | $5.6 | $1,399,205 | 0 (Direct) | View |
| 2022-05-24 Sale | 2022-05-26 5:24 pm | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 915,270 | $5.6 | $5,125,512 | 0 (Direct) | View |
| 2022-05-24 Sale | 2022-05-26 5:23 pm | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President and CEO | 2,862,459 | $5.6 | $16,029,770 | 0 (Direct) | View |
| 2022-05-24 Sale | 2022-05-26 5:22 pm | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 79,645 | $5.6 | $446,012 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-03 Option Award | 2022-03-04 6:38 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO | 86,814 | $0 | 2,488,360 (Direct) | View |
| 2022-03-03 Tax Withholding | 2022-03-04 6:38 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO | 37,695 | $3.8 | 2,488,360 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-04 6:36 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 27,780 | $0 | 791,036 (Direct) | View |
| 2022-03-03 Tax Withholding | 2022-03-04 6:36 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 11,506 | $3.8 | 791,036 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-04 6:34 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary | 26,044 | $0 | 616,609 (Direct) | View |
| 2022-03-03 Tax Withholding | 2022-03-04 6:34 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary | 13,635 | $3.8 | 616,609 (Direct) | View |
| 2022-02-16 Option Award | 2022-02-18 7:19 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary | 23,068 | $0 | 604,200 (Direct) | View |
| 2022-02-16 Tax Withholding | 2022-02-18 7:19 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary | 13,299 | $3.66 | 604,200 (Direct) | View |
| 2022-02-16 Option Award | 2022-02-18 7:16 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 24,606 | $0 | 774,762 (Direct) | View |
| 2022-02-16 Tax Withholding | 2022-02-18 7:16 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 11,496 | $3.66 | 774,762 (Direct) | View |
| 2022-02-16 Option Award | 2022-02-18 7:13 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO | 76,893 | $0 | 2,439,241 (Direct) | View |
| 2022-02-16 Tax Withholding | 2022-02-18 7:13 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO | 34,282 | $3.66 | 2,439,241 (Direct) | View |
| 2021-10-26 Ownership | 2022-02-04 7:09 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 125,000 | $0 | 170,575 (Direct) | View |
| 2021-10-27 Option Award | 2021-10-29 6:14 pm | 2022-10-27 2031-10-27 | ANTARES PHARMA INC. | ATRS | Volkart Carmen B Director | 55,916 | $0 | 55,916 (Direct) | View |
| 2021-08-27 Tax Withholding | 2021-08-31 6:26 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 13,820 | $4 | 295,575 (Direct) | View |
| 2021-08-27 Option Award | 2021-08-31 6:26 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 24,679 | $2.24 | 295,575 (Direct) | View |
| 2021-08-27 Exercise | 2021-08-31 6:26 pm | 2021-08-27 2021-09-08 | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 24,679 | $0 | 295,575 (Direct) | View |